ebselen has been researched along with Shock, Septic in 2 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimohashi, N | 1 |
Nakamuta, M | 1 |
Uchimura, K | 1 |
Sugimoto, R | 1 |
Iwamoto, H | 1 |
Enjoji, M | 1 |
Nawata, H | 1 |
Konz, KH | 1 |
Tiegs, G | 1 |
Wendel, A | 1 |
2 other studies available for ebselen and Shock, Septic
Article | Year |
---|---|
Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells.
Topics: Animals; Antioxidants; Azoles; Blotting, Western; Cell Nucleus; Cells, Cultured; Cyclooxygenase 1; C | 2000 |
Protection by ebselen against endotoxin shock in rats or mice sensitized by galactosamine.
Topics: Animals; Azoles; Chemical and Drug Induced Liver Injury; Fatty Acids, Unsaturated; Galactosamine; Gl | 1987 |